Perampanel

Brand name: Fycompa

Rank #374 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$25.9M

Total Cost

Share:

20,876

Total Claims

$25.9M

Total Cost

788

Prescribers

$1,241

Cost per Claim

621

Beneficiaries

22,555

30-Day Fills

$33K

Avg Cost/Provider

26

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$25.9M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $25.9M total

🔎 Data Overview

💰

At $1,241 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $41,728 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Perampanel

#ProviderSpecialtyLocationClaimsCost
1Jessica BishopPhysician AssistantBoise, ID368$456K
2Olga TaraschenkoNeurologyOmaha, NE217$260K
3Brenda WuNeurologyNew Brunswick, NJ161$223K
4Graham HuesmannNeurologyUrbana, IL161$219K
5Holly MaggianoNeurologyWarren, OH160$199K
6Victor BitonNeurologyLittle Rock, AR154$183K
7Melissa CarranNeurologyCamden, NJ156$178K
8Aristoteles Pena-MichesPediatric MedicineMonroe, LA120$175K
9Charles UgokweNeurologyAlexandria, LA131$160K
10Toufic FakhouryNeurologyLexington, KY126$158K
11David ChabollaNeurologyJacksonville, FL118$157K
12Lauren AlvarezPhysician AssistantBrooklyn, NY108$157K
13Samir Al-KabbaniNeurologyKnoxville, TN128$152K
14Tenzin LamaNurse PractitionerStanford, CA72$152K
15Mohamad HadidiNeurologyClarksdale, MS132$148K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
371Brinzolamide/Brimonidine Tart (Simbrinza)$26.3M97,240
372Rotigotine (Neupro)$26.2M23,665
373Chlorpromazine Hcl (Chlorpromazine Hcl)$25.9M78,710
374Perampanel (Fycompa)$25.9M20,876
375Timolol Maleate (Timolol Maleate)$25.8M1,129,537
376Amitriptyline Hcl (Amitriptyline Hcl)$25.8M1,295,043
377Tezepelumab-Ekko (Tezspire)$25.6M5,900

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology